Viewing Study NCT04040322


Ignite Creation Date: 2025-12-18 @ 9:58 AM
Ignite Modification Date: 2025-12-23 @ 6:58 PM
Study NCT ID: NCT04040322
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module